Purpose: To analyze the prognostic effects of our selecting surgical procedures for gallbladder carcinoma based on the extent of tumor invasion.
Introduction
The incidence of gall bladder and bile duct cancer in Japan was approximately 21,000 in 2008, and accounted for 2.8% of all cancer patients and 18,000 patients died annually [1] . The prognosis for gallbladder and bile duct carcinoma is poor. The complete resection (R0) surgical procedure is considered to be the only way to cure the patient [2] .
Gallbladder Carcinoma (GC) has a particularly low incidence, and as a result, few randomized control trials have been conducted to determine the optimal surgical procedure. There is evidence that the optimal treatment modality is a simple cholecystectomy for a GC with a mucosal invasion (T1a) [3, 4] . Even still, there are many controversial issues concerning the surgical treatments for GC that invade beyond the muscular is (>T1b) [5, 6] . The necessity of an extra hepatic bile duct resection (EHBDR) with a lymph node dissection for the treatment of a T2 GC has been consistently discussed [7, 8] . However, we have no clear evidence to show the effectiveness of the EHBDR procedure. Furthermore, the need for an extended and radical operation for a T3 level invasion with an extensive GC has also been discussed [9, 10] .
We retrospectively analyzed 35 patients with GC who underwent surgical treatment in our hospital. We herein describe our selection of surgical procedure according to the extent of the tumor invasion (T1, T2, and T3) and clinical course of the patients in each group.
Materials and Methods
Eighty six patients with GC had been listed in the cancer registration in our hospital between the time period of January, 2007 and December, 2013. Among these, 35 (16 of male and 19 female) patients underwent the surgical treatment. The mean age of the patients was 73 ± 8 years of age (range, 54-88). We reviewed the patients' clinical records of the surgical procedure, including the extent of lymph node dissection, the survival data and the pathological findings, including the extent of tumor invasion, vascular invasion, and the number of lymph node metastasis, the histological grade and final stage according to the UICC TNM criteria.
The survival time was analyzed by the Kaplan-Meier method and the statistical significances were tested with the log-rank test using the SPSS ver.21 statistical software.
Patients were divided into three groups: 1) T1; the tumor invaded the mucosa (T1a) and muscular is (T1b), 2) T2; the tumor invaded the peri muscular connective tissue without extension beyond the serosa and 3) T3; the tumor perforated the serosa or directly invaded other organs, including liver and common bile duct.
Eight patients in the T1 group, 15 patients in the T2 group, and 12 patients in the T3 group with GC were analyzed for the surgical procedures and their prognosis.
Results
Mean survival time of T1, T2 and T3 GC was 62 ± 0, 48 ± 6 and 13 ± 3, respectively. And significant differences were observed between T1-T3 (p=0.00), and T2-T3 (p=0.00) on log-rank test (Figure 1 ). The 1, 3 and 5 year survival rates of all (n=35) patients with GC were 72, 49, and 42%, respectively.
All of the selected factors such as the extent of tumor invasion (pT), vascular invasion, lymph node metastasis, histological grade and the f-Stage according to the UICC TNM classification, significantly correlated with mean survival time (MST) of patients with GC ( Table 1 ). The extent of the tumor invasion is one of the most important prognostic factors which could be predicted by preoperative evaluations.
Among the eight patients with T1 (T1a;6, T1b;2), 4 patients underwent an Open Cholecystectomy (OC) only, 2 patients underwent an OC or an extent cholecystectomy (ExC; cholecystectomy with wedge resection or a segmentectomy of the liver) with a Lymph Node Dissection (LND) and 2 patients underwent a (ExC) and a LND with an Extra Hepatic Bile Duct Resection (EHBDR) ( Table 2) . Two of 8 patients with T1, developed an unexpected recurrence regardless the kinds of surgical procedure. One patient with T1b developed a regional lymph node metastasis despite the diagnosis of n0 in the dissected LN. Another patient with a T1a GC whose nuclear grade was G3 developed an unexpected LN metastasis.
Of the 15 patients with the T2 GC, the prognosis of 11of the patients with T2n-(f stage 2) was satisfactory ( Table 2,3) . One patient who received a Laparoscopic Cholecystectomy (LC) developed a peritoneal metastasis and died. The other 10 patients had no recurrence of disease, and of these patients, 1 patient underwent an OC only, 4 (Table 4) . Although, the 6 patients who underwent an ExC+LND with an EHBDR, were expected to achieve a curative operation (R0), all of these patients died. Most of the patients developed liver and peritoneal metastases.
Discussion
The screening program for hepato-biliary morbidity using Mean survival time of T1, T2 and T3 GC was 62 ± 0, 48 ± 6 and 13 ± 3 months, respectively. Statistical significance with log-rank test are T1-T2 (p=0.17), T1-T3 (p=0.00), and T2-T3 (p=0.00). abdominal ultrasound has been widespread in Japan for several decades [11] . Consequently, the frequency of incidental gallbladder carcinoma that is being diagnosed during laparoscopic surgery for benign diseases is increasing [12, 13] . However, the prognosis for patients with GC has not been improved [14, 15] .
There are evidences that the optimal treatment modality is a simple cholecystectomy for a GC with mucosal invasion (T1a) [3, 4] . However, there are still many controversial issues concerning the surgical treatment of GC that invades beyond the muscularis (>T1b) [5, 6] . Our selection of surgical procedure for T1 GC was in accordance to the standard surgery mentioned above. However, an extraordinary recurrence happened in 2 of the 8 cases (25%). A LND should be performed for the cases that are expected to be associated with invasion of the muscularis.
Lymph node metastasis is a well-known prognostic indicator, and its incidence varies depending on the depth of the mural invasion and the depth is scored as follows: pT1a; 0-2.5%, pT1b; 5-16%, pT2; 9-30%, T3; 39-72%, and T4; 67-80% [15] . We should be aware of the necessity for a lymph node dissection; however, there is no consensus on the optimal extent of the lymph node dissection for GC surgery.
The clinical significance of the extra hepatic bile duct resection (EHBDR) in radical surgery has been extensively discussed. However, it was subsequently found that an EHBDR is not associated with an increased in survival [16, 17] . An EHBDR should be selectivity performed in specific types of cases, such as in a GC with an extra hepatic bile duct invasion. A multi-centric questionnaire survey by the Japanese Society of Biliary Surgery [18] concluded that EHBDR may be unnecessary in advanced GC without a direct infiltration of the hepato duodenal ligament and the cystic duct, even in the T2 gallbladder carcinoma with lymph node metastasis.
In our experiments, we achieved good survival in the T2n0 cases with an ExC and a LND with and without the EHBD resection. However, complete resection (R0) could not be achieved by a LND without the EHBDR in one patient with T1 GC. In contrast, we had 3 cases of survival with T2n+ by an ExC+LND with an EHBDR. We decided to select an ExC+LND with an EHBDR for the patients with T1/T2 and an expected LN metastasis.
Patients with a T3/T4 GC rarely receive the benefit of an extended radical resection because the risk of having a lymph node metastasis beyond the hepatoduodenal ligament, and the latent liver or peritoneal metastasis is high [19] . Most of the T3 patients in this paper developed distant metastases and peritoneal disseminations, which indicates that a more extended radical resection does not improve the prognosis of T3 GC.
We understood through this investigation, that the most important fact to improve the prognosis of a patient with GC is early detection. The screening program to diagnose T1 GC needs to be investigated.
Another important issue to consider is the nonsurgical treatment for GC. Recently, the effect of chemotherapies such as a fluoro pyrimidine containing regimen, gemcitabine, or a combination of gemcitabine and cisplatin has raised concerns. We do not have any established data that indicates the survival benefit of adjuvant chemotherapies yet. However physicians should consider administering these anti-cancer drugs for patients diagnosed to have T3/T4 or T2 with lymphno metastasis or any T with positive margin
